EMD Serono Appoints Joseph Leveque as U.S. Chief Medical Officer
News Oct 03, 2015
EMD Serono has announced the appointment of Joseph Leveque, M.D. as U.S. Chief Medical Officer. In this role, Dr. Leveque will be responsible for working with the regulatory, medical and development teams to enhance EMD Serono’s clinical presence in the U.S. and to drive the execution of key medical initiatives.
Dr. Leveque brings more than 20 years of experience in the areas of strategic leadership, driving medical and clinical programs, as well as life cycle management. He has served as the medical lead in a number of biopharmaceutical roles, and has wide industry expertise across therapeutic areas, with a focus in oncology and immuno-oncology.
“Dr. Leveque’s substantial experience in managing integrated global medical affairs teams will be significant to furthering our specialty care focus in neurology, oncology, fertility, and endocrinology and bringing our pipeline forward,” said Paris Panayiotopoulos, President and Managing Director of EMD Serono. “In the U.S., Dr. Leveque will collaborate closely with our global medical and R&D organizations, and will play a key role in advancing our commitment to innovation and bringing new therapeutic options to patients, particularly those with difficult to treat diseases.”
Dr. Leveque will report to Steven Hildemann, Global Chief Medical Officer and Head of Global Medical Affairs and Drug Safety for the biopharma business of Merck KGaA, Darmstadt, Germany and will be a member of the Global Medical Affairs and EMD Serono U.S. Leadership Teams.
Most recently, Dr. Leveque was at Bristol-Myers Squibb, where he served as the head of U.S. Medical for Oncology. At Bristol-Myers Squibb, Dr. Leveque was responsible for providing strategic leadership and management for marketed and near-term pipeline oncology assets.
Previous to Bristol Myers Squibb, Dr. Leveque has also held medical affairs leadership positions at Onyx Pharmaceuticals, Inc., Cephalon and Amgen, Inc.
Dr. Leveque holds an M.D. from University of Texas and his MBA from Wharton Business School.
He will be based in Rockland, Massachusetts.
Doctors Rely on More Than Just Data During a DiagnosisNews
Computer scientists examine how a doctor’s “gut feeling” influences how many tests they order for patientsREAD MORE
Lab Innovations 2018 – Registration Opens and Keynotes AnnouncedNews
Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.READ MORE